Souhaitez-vous accéder aux communiqués récents ?
Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.
-
SAN DIEGO, March 03, 2026 (GLOBE NEWSWIRE) -- Fate Therapeutics, Inc. (NASDAQ: FATE), a clinical-stage biopharmaceutical company dedicated to bringing a first-in-class pipeline of induced...
-
PRINCETON, N.J., Feb. 24, 2026 (GLOBE NEWSWIRE) -- UroGen Pharma Ltd. (Nasdaq: URGN), a biotech company dedicated to developing and commercializing innovative solutions that treat urothelial and...
-
ORANGE, Calif., Feb. 23, 2026 (GLOBE NEWSWIRE) -- Alignment Healthcare, Inc. (NASDAQ: ALHC), today announced that it will present at the Leerink Partners Global Healthcare Conference in Miami,...
-
Surrozen to Present at Upcoming Healthcare Investor Conference
-
VERO BEACH, Fla., Jan. 12, 2026 (GLOBE NEWSWIRE) -- Processa Pharmaceuticals, Inc. (Nasdaq: PCSA), a clinical-stage biopharmaceutical company developing Next Generation Cancer (NGC) therapies, today...
-
Myriad announced select unaudited preliminary results for the 4th quarter and full year ended Dec. 31, 2025, provided full year 2026 financial guidance.
-
Sam Raha, president and CEO of Myriad, will present at the 44th Annual J.P. Morgan Healthcare Conference in San Francisco on Jan. 14, at 5:15 pm PT.
-
InnovAge Announces Participation at the 44th Annual J.P. Morgan Healthcare Conference
-
Alignment Healthcare, Inc. (NASDAQ: ALHC) will present at the 44th Annual J.P. Morgan Healthcare Conference on Wednesday, Jan. 14, at 10:30 a.m. PST.
-
Sanuwave to Participate in the 44th Annual J.P. Morgan Healthcare Conference